Treasurer of the State of North Carolina’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$827K Buy
39,466
+846
+2% +$19.1K ﹤0.01% 960
2025
Q4
$888K Sell
38,620
-1,763
-4% -$58K ﹤0.01% 962
2025
Q3
$1.22M Sell
40,383
-1,575
-4% -$47.2K ﹤0.01% 951
2025
Q2
$1.53M Buy
41,958
+1,327
+3% +$47.8K ﹤0.01% 934
2025
Q1
$1.47M Buy
40,631
+1,580
+4% +$65.7K 0.01% 902
2024
Q4
$1.64M Sell
39,051
-330
-0.8% -$16.4K 0.01% 902
2024
Q3
$2.19M Buy
39,381
+1,410
+4% +$71.8K 0.01% 869
2024
Q2
$1.56M Buy
37,971
+2,878
+8% +$123K 0.01% 901
2024
Q1
$1.64M Buy
35,093
+240
+0.7% +$11.3K 0.01% 884
2023
Q4
$1.67M Buy
34,853
+5,150
+17% +$200K 0.01% 896
2023
Q3
$1.06M Buy
29,703
+150
+0.5% +$5.94K 0.01% 946
2023
Q2
$1.36M Buy
29,553
+360
+1% +$16.7K 0.01% 923
2023
Q1
$1.17M Buy
29,193
+210
+0.7% +$9.01K 0.01% 924
2022
Q4
$1.34M Buy
28,983
+370
+1% +$14.6K 0.01% 892
2022
Q3
$1.19M Buy
28,613
+370
+1% +$19K 0.01% 926
2022
Q2
$1.69M Buy
28,243
+4,254
+18% +$262K 0.01% 869
2022
Q1
$1.74M Buy
23,989
+380
+2% +$26.4K 0.01% 854
2021
Q4
$1.99M Buy
23,609
+400
+2% +$32.5K 0.01% 821
2021
Q3
$2.09M Buy
23,209
+779
+3% +$70.4K 0.01% 803
2021
Q2
$2.14M Buy
+22,430
New +$2.34M 0.01% 802

Other funds holding RARE

Treasurer of the State of North Carolina's RARE Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Ultragenyx Pharmaceutical (RARE) stake by 2.2% in Q1 2026, buying an estimated $19.1K and bringing the position to 39,466 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Treasurer of the State of North Carolina first reported a position in RARE in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.19M in Q3 2024. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Treasurer of the State of North Carolina held 39,466 shares of Ultragenyx Pharmaceutical worth $827K as of Q1 2026.
  • Treasurer of the State of North Carolina bought 846 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $19.1K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #960 holding.
  • Treasurer of the State of North Carolina first reported a position in Ultragenyx Pharmaceutical in Q2 2021 and has held it in 20 quarters since.
  • Treasurer of the State of North Carolina's Ultragenyx Pharmaceutical position peaked at $2.19M in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.